160 related articles for article (PubMed ID: 6652000)
1. Haemodynamic response to intravenous hydralazine in patients with pulmonary hypertension.
McGoon MD; Seward JB; Vlietstra RE; Choo MH; Moyer TP; Reeder GS
Br Heart J; 1983 Dec; 50(6):579-85. PubMed ID: 6652000
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effect of hydralazine in interstitial lung disease patients with cor pulmonale. Immediate and short-term evaluation at rest and during exercise.
Lupi-Herrera E; Seoane M; Verdejo J; Gomez A; Sandoval J; Barrios R; Martinez W
Chest; 1985 May; 87(5):564-73. PubMed ID: 3987368
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the acute hemodynamic effects of prostacyclin and hydralazine in primary pulmonary hypertension.
Groves BM; Rubin LJ; Frosolono MF; Cato AE; Reeves JT
Am Heart J; 1985 Dec; 110(6):1200-4. PubMed ID: 3907315
[TBL] [Abstract][Full Text] [Related]
4. Oral hydralazine therapy for primary pulmonary hypertension.
Rubin LJ; Peter RH
N Engl J Med; 1980 Jan; 302(2):69-73. PubMed ID: 7350435
[TBL] [Abstract][Full Text] [Related]
5. Adverse effect of hydralazine in patients with primary pulmonary hypertension.
Kronzon I; Cohen M; Winer HE
JAMA; 1982 Jun; 247(22):3112-4. PubMed ID: 7077805
[No Abstract] [Full Text] [Related]
6. Hemodynamic effects of urapidil in patients with pulmonary hypertension. A comparative study with hydralazine.
Adnot S; Defouilloy C; Brun-Buisson C; Abrouk F; Piquet J; Lemaire F
Am Rev Respir Dis; 1987 Feb; 135(2):288-93. PubMed ID: 3813189
[TBL] [Abstract][Full Text] [Related]
7. Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators.
Houde C; Bohn DJ; Freedom RM; Rabinovitch M
Br Heart J; 1993 Nov; 70(5):461-8. PubMed ID: 8260279
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamics at rest and during exercise after oral hydralazine in patients with cor pulmonale.
Rubin LJ; Peter RH
Am J Cardiol; 1981 Jan; 47(1):116-22. PubMed ID: 7457397
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic effects of intravenous hydralazine in pregnant women with severe hypertension.
Kuzniar J; Skret A; Piela A; Szmigiel Z; Zaczek T
Obstet Gynecol; 1985 Oct; 66(4):453-8. PubMed ID: 4047535
[TBL] [Abstract][Full Text] [Related]
10. The role of hydralazine therapy for pulmonary arterial hypertension of unknown cause.
Lupi-Herrera E; Sandoval J; Seoane M; Bialostozky D
Circulation; 1982 Apr; 65(4):645-50. PubMed ID: 7060241
[TBL] [Abstract][Full Text] [Related]
11. Deleterious effects of hydralazine in patients with pulmonary hypertension.
Packer M; Greenberg B; Massie B; Dash H
N Engl J Med; 1982 Jun; 306(22):1326-31. PubMed ID: 7070457
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary vascular effects of hydralazine in a canine preparation of pulmonary thromboembolism.
Ducas J; Girling L; Schick U; Prewitt RM
Circulation; 1986 May; 73(5):1050-7. PubMed ID: 3698227
[TBL] [Abstract][Full Text] [Related]
13. The effects of hydralazine on exercise capacity in pulmonary hypertension secondary to chronic obstructive pulmonary disease.
Dal Nogare AR; Rubin LJ
Am Rev Respir Dis; 1986 Mar; 133(3):385-9. PubMed ID: 3954247
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effect of hydralazine in advanced, stable chronic obstructive pulmonary disease with cor pulmonale. Immediate and short-term evaluation at rest and during exercise.
Lupi-Herrera E; Seoane M; Verdejo J
Chest; 1984 Feb; 85(2):156-63. PubMed ID: 6692695
[TBL] [Abstract][Full Text] [Related]
15. Detrimental effects of hydralazine in patients with chronic air-flow obstruction and pulmonary hypertension. A combined hemodynamic and radionuclide study.
Tuxen DV; Powles AC; Mathur PN; Pugsley SO; Campbell EJ
Am Rev Respir Dis; 1984 Mar; 129(3):388-95. PubMed ID: 6322627
[TBL] [Abstract][Full Text] [Related]
16. Acute hemodynamic effects of pinacidil and hydralazine in essential hypertension.
Carlsen JE; Kardel T; Lund JO; McNair A; Trap-Jensen J
Clin Pharmacol Ther; 1985 Mar; 37(3):253-9. PubMed ID: 2857601
[TBL] [Abstract][Full Text] [Related]
17. Effects of oral hydralazine on gas exchange in patients with cor pulmonale.
Miller MJ; Chappell TR; Cook W; De Olazabal JR; Rubin LJ
Am J Med; 1983 Dec; 75(6):937-42. PubMed ID: 6650548
[TBL] [Abstract][Full Text] [Related]
18. Acute effect of hydralazine administration on pulmonary artery hemodynamics in dogs with chronic heartworm disease.
Atkins CE; Keene BW; McGuirk SM; Sato T
Am J Vet Res; 1994 Feb; 55(2):262-9. PubMed ID: 8172418
[TBL] [Abstract][Full Text] [Related]
19. Effect of vasodilators at rest and during exercise in young adults with cystic fibrosis and chronic cor pulmonale.
Geggel RL; Dozor AJ; Fyler DC; Reid LM
Am Rev Respir Dis; 1985 Apr; 131(4):531-6. PubMed ID: 3994148
[TBL] [Abstract][Full Text] [Related]
20. Afterload reduction treatment for large ventricular septal defects. Dependence of haemodynamic effects of hydralazine on pretreatment systemic blood flow.
Nakazawa M; Takao A; Shimizu T; Chon Y
Br Heart J; 1983 May; 49(5):461-5. PubMed ID: 6838733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
